Financials data is unavailable for this security.
View more
Year on year StageZero Life Sciences Ltd 's revenues fell -25.12% from 5.07m to 3.80m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a loss of 7.48m to a larger loss of 11.42m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in USDView more
In 2022, cash reserves at StageZero Life Sciences Ltd fell by 1.71m. Cash Flow from Financing totalled 1.83m or 48.29% of revenues. In addition the company used 3.53m for operations while cash from investing was breakeven.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.112 |
---|---|
Tangible book value per share | -0.112 |
More ▼
Balance sheet in USDView more
Current ratio | 0.02 |
---|---|
Quick ratio | 0.0176 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼